Document is current
Any future updates will be listed below
-
Authors
Canizares, Natalia Vasquez
Pain, Clare E.
Zulian, Francesco
Yildiz, Amra Adrovic
Appenzeller, Simone
Marrani, Edoardo
Del Giudice, Emanuela
Petaccia, Antonella
Tirelli, Francesca
Simonini, Gabriele
Çakan, Mustafa
Cattalini, Marco
Julio, Paulo Rogerio
Torok, Kathryn
Khubchandani, Raju
Kasapcopur, Ozgur
Robinson, Lauren
Al-Abadi, Eslam
Gunalp, Aybuke
Lu, Meiping
Lythgoe, Hanna
Robinson, Amanda
Sozeri, Betul
Shenoi, Susan
Willis, Emily
Clarke, Katherine
Zheng, Rongjun
Castaldi, Biagio
Leone, Valentina
Maniscalco, Valerio
Stead, Lucy
Ambartsumyan, Lusine
Rosser, Franziska
Duong, Phuoc
Minuti, Aurelia
Li, Suzanne C.
Twilt, Marinka
-
Funding
Funding for this research was provided by:
Childhood Arthritis and Rheumatology Research Alliance (App_207)
- License Information
-
More Information
Article History
Received: 30 January 2025
Accepted: 22 April 2025
First Online: 2 May 2025
Declarations
:
: The study was approved by the Albert Einstein College of Medicine Institutional Review Board (# 2020–12326) under Exempt 2: Research involving the use of educational tests (cognitive, diagnostic, aptitude, achievement), survey procedures, interview procedures or observation of public behavior. HIPAA does not apply to this study.
: Not applicable.
: • NVC received grant funds from the Childhood Arthritis and Rheumatology Research Alliance and the Arthritis Foundation for the development and implementation of this project. Consulting services were paid to CP, FZ and SL using these funds. • NVC, SL, and KT have received consulting payments from Boehringer Ingelheim for their involvement in planning and designing clinical trials in Juvenile Systemic Sclerosis. • SL and FZ receive royalty payments from Wolters Kluwer for educational material Published in UpToDate related to Juvenile Scleroderma.
